We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




3D Mammography Helps Detect Breast Cancer Earlier

By HospiMedica International staff writers
Posted on 06 Mar 2016
A new study concludes that screening with digital breast tomosynthesis (DBT) combined with digital mammography (DM) increases breast cancer detection rates. More...


Researchers at the University of Pennsylvania (Philadelphia, USA) conducted a retrospective, four-year study of screening mammography metrics to determine if the improved outcomes observed after initial implementation of DBT screening are sustainable over time, and to evaluate the effect of more than one DBT screening at the individual level. In all, 44,468 screening events were performed on 23,958 unique women. The researchers then assessed the differences in outcomes between each DBT year and the DM year.

The researchers evaluated the results between groups of women with only 1, 2, or 3 DBT screenings, and also calculated the odds of recall adjusted for age, race and ethnicity, breast density, and prior mammograms. The results showed that the yearly rate of women called back for additional imaging decreased with the number of years they received three dimensional (3D) DBT mammography exams. Per 1,000 women, 130 were recalled in the first year of 3D mammography exams, 78 after two years, and only 59 after three years.

The analysis also showed that the yearly rate of women called back for additional imaging with 3D DBT mammography was consistently lower than the rate with standard 2D mammography. Concomitantly, the cancer detection rate per 1,000 women increased from 4.6 with 2D mammography to 5.5 in year one of 3D DBT mammography screenings, 5.8 in year two, and 6.1 in year three. Interval cancer rates decreased from 0.7% with the use of DM to 0.5% with the use of DBT. The study was published on February 18, 2016, in JAMA Oncology.

“We found that reduction in recall was sustainable at a population level, with additional reduction in recall as women returned for a second and third DBT examination,” concluded senior author Emily Conant, MD, and colleagues of the department of radiology and the computational breast imaging group. “These findings reaffirm that 3D mammography is a better mammogram for breast cancer screening […] and are an important step toward informing policies so that all women can receive 3D mammography for screening.”

DBT mammograms use low dose X-rays to create a 3D image of the breast, which can then be viewed in narrow slices, similarly to CT scan images. While in conventional 2D mammography overlapping tissues can mask suspicious areas, 3D images eliminate the overlap, making abnormalities easier to recognize. Experts estimate that 3D mammography will replace conventional mammography within ten years.

Related Links:

University of Pennsylvania



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Resorbable Bovine Collagen Membrane
GenDerm
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.